Search research articles
Contact Us
Filters
Showing results (21-30 of 120) with videos related to
Page
of 12
Sort By:
Expert Opinion on Pharmacotherapy
|
December 8, 2006
Abacavir/lamividune combination in the treatment of HIV-1 infection: a review
Laura Waters, Graeme Moyle
American Journal of Therapeutics
|
November 27, 2009
Antiretroviral therapy with heart
Paul Randell, Graeme Moyle
Lancet (London, England)
|
July 6, 2004
Unexpected drug interactions and adverse events with antiretroviral drugs
Graeme Moyle, Marta Boffito
Journal of HIV Therapy
|
July 9, 2004
Does atazanavir cause lipodystrophy?
Brian G Gazzard, Graeme Moyle
AIDS (London, England)
|
May 19, 2010
Does earlier HIV RNA suppression provide long-term benefits?
Graeme Moyle, Ralph Demasi, Andrew Hill
AIDS Clinical Care
|
March 4, 2009
Antiretroviral rounds. Too many options?
Sharon Walmsley, Timothy Wilkin, Graeme Moyle
Expert Opinion on Pharmacotherapy
|
May 23, 2015
HIV integrase inhibitors: a new era in the treatment of HIV
Jose Luis Blanco, Gary Whitlock, Ana Milinkovic, et al.
AIDS (London, England)
|
July 23, 2009
Concurrent use of statins does not influence efficacy of maraviroc in Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment-Experienced Patients 1 and 2 trials
Graeme Moyle, Natasa Rajicic, James Goodrich, et al.
Clinical Therapeutics
|
March 5, 2004
Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studies
Graeme Moyle, Will Sawyer, Matthew Law, et al.
Antiviral Therapy
|
October 7, 2016
An open-label, randomized study of the impact on insulin sensitivity, lipid profile and vascular inflammation by treatment with lopinavir/ritonavir or raltegravir in HIV-negative male volunteers
Paul Randell, Akil Jackson, Ana Milinkovic, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 120) with videos related to
Sort By:
Page
of 12
Expert Opinion on Pharmacotherapy
|
December 8, 2006
Abacavir/lamividune combination in the treatment of HIV-1 infection: a review
Laura Waters, Graeme Moyle
American Journal of Therapeutics
|
November 27, 2009
Antiretroviral therapy with heart
Paul Randell, Graeme Moyle
Lancet (London, England)
|
July 6, 2004
Unexpected drug interactions and adverse events with antiretroviral drugs
Graeme Moyle, Marta Boffito
Journal of HIV Therapy
|
July 9, 2004
Does atazanavir cause lipodystrophy?
Brian G Gazzard, Graeme Moyle
AIDS (London, England)
|
May 19, 2010
Does earlier HIV RNA suppression provide long-term benefits?
Graeme Moyle, Ralph Demasi, Andrew Hill
AIDS Clinical Care
|
March 4, 2009
Antiretroviral rounds. Too many options?
Sharon Walmsley, Timothy Wilkin, Graeme Moyle
Expert Opinion on Pharmacotherapy
|
May 23, 2015
HIV integrase inhibitors: a new era in the treatment of HIV
Jose Luis Blanco, Gary Whitlock, Ana Milinkovic, et al.
AIDS (London, England)
|
July 23, 2009
Concurrent use of statins does not influence efficacy of maraviroc in Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment-Experienced Patients 1 and 2 trials
Graeme Moyle, Natasa Rajicic, James Goodrich, et al.
Clinical Therapeutics
|
March 5, 2004
Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studies
Graeme Moyle, Will Sawyer, Matthew Law, et al.
Antiviral Therapy
|
October 7, 2016
An open-label, randomized study of the impact on insulin sensitivity, lipid profile and vascular inflammation by treatment with lopinavir/ritonavir or raltegravir in HIV-negative male volunteers
Paul Randell, Akil Jackson, Ana Milinkovic, et al.
Page
of 12